ALK and ovarian carcinoma: Furthermore, previously published studies have demonstrated overexpression of native ALK RNA and protein in aggressive subsets of metastatic colorectal carcinoma6, malignant melanoma7,11, fusion-positive rhabdomyosarcoma4,5, and breast and ovarian carcinomas in need of novel therapies9,11.